EMERYVILLE, Calif., May 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.
“We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris. “Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]


Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump
Freedom Finance and Binance Join Forces in Digital Assets
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA
Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16%
Airbus Cuts Jet Production Target Amid Pratt & Whitney Engine Shortages, Q4 Profit Jumps 17%
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations
India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi 



